Somatic POLE mutations affecting proofreading are relatively rare, typically observed in approximately 2%–8% of colorectal cancers and approximately 7%–15% of endometrial cancers, and less commonly in other tumors (3). The gene discussed is POLE; the disease is colorectal cancer.